MedTrace Logo

A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma

NCT02110134 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2020-11-17

No results posted yet for this study

Summary

The purpose of this study is to compare a hydroquinone skin care regimen alone to a combination of Revlite Laser treatment with a hydroquinone skin care regimen for the treatment of melasma.

Conditions

  • Melasma

Interventions

DEVICE

Revlite Laser System with hydroquinone skin care regimen

Revlite Laser System with hydroquinone skin care regimen for the Treatment of Melasma

OTHER

Hydroquinone skin care regimen

Hydroquinone skin care regimen for the Treatment of Melasma

Sponsors & Collaborators

  • Cynosure, Inc.

    lead INDUSTRY

Principal Investigators

  • Patricia Krantz · Cynosure, Inc.

Study Design

Allocation
NON_RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02110134 on ClinicalTrials.gov